Amgen 2020 outlook falls short of Street estimates; shares slump

Amgen Inc on Thursday forecast 2020 earnings well short of Wall Street estimates, sending shares of the largest U.S. biotechnology company down 2.5%.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News